Opera Limited pre-announced its Q3 revenue at $182.8 million, a 20% increase year-over-year, and an adjusted EBITDA of $43.2 million, slightly above expectations. The company remains optimistic despite recent share price volatility driven by AI sector fluctuations. Key areas to watch include Q4 guidance, user and ARPU growth, advertising momentum, and AI integration in its browser products. Risks involve AI market volatility, potential stagnation in users or ARPU, rising costs, and competition from larger tech players. Full Q3 results are expected on November 17.
Opera Limited's Q3 revenue preview shows a 20% year-over-year increase to $182.8 million, with adjusted EBITDA slightly above expectations. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 13, 2026 22:41 WIB: out of 150 priced US tech stocks, 43 rose and 106 fell. Notable movers include Bitdeer Technologies Group (BTDR) down 12.64% at USD 5.36 with a typical hold time of 17 days and Pluang order activity of 11% Sell / 89% Buy, Applied Digital Corporation (APLD) down 10.65% at USD 15.14, and Cipher Mining Inc (CIFR) down 9.93% at USD 6.44.
Susan R. Burns, Ph.D., President of the University of Mount Saint Vincent, has been awarded the 2027 Courageous Leadership Award for her visionary and bold leadership. Since 2021, she has led the university through significant transformation, includi...
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...
